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a  b  s  t  r  a  c  t
CD4+ T-cell  priming  is  an essential  step  in vaccination  due  to the  key  role  of T  helper  cells  in  driving
both  effector  and memory  immune  responses.  Here  we  have  characterized  in C57BL/6  mice  the  T  helper
subtype  differentiation  among  tetramer-speciﬁc  CD4+ T cells  primed  by subcutaneous  immunization  with
the tuberculosis  vaccine  antigen  H56  plus  the  adjuvant  CAF01.  Peptide-speciﬁc  population  identiﬁed
by  the MHC  class  II tetramers  differentiated  into  several  T helper  subtypes  upon  antigen  encounter,
and  the  frequency  of subpopulations  differed  according  to  their  localization.  Th1  (CXCR3+T-bet+),  Tfh
(CXCR5+PD-1+Bcl-6+) and  RORt+ cells  were  induced  in  the lymph  nodes  draining  the immunization
site  (dLN),  while  Th1  cells  were  the  predominant  subtype  in  the spleen.  In addition,  CD4+ T  cells  co-
expressing  multiple  T-cell  lineage-specifying  transcription  factors  were  also  detected.  In  the lungs,  most
of the tetramer-binding  T  cells  were  RORt+,  while  Tfh and Th1  cells  were  absent.  After  boosting,  a  higher
frequency  of tetramer-binding  cells  co-expressing  the  markers  CD44  and  CD127  was detected  compared
to  primed  cells,  and  cells  showed  a prevalent  Th1 phenotype  in  both  dLN  and spleens, while  Tfh cells  were
signiﬁcantly  reduced.  In conclusion,  these  data  demonstrate  that  parenteral  immunization  with  H56 and
CAF01  elicits  a distribution  of  antigen-speciﬁc  CD4+ T cells  in  both  lymphoid  tissues  and  lungs,  and  gives
rise  to multiple  T helper  subtypes,  that  differ  depending  on localization  and  following  reactivation.
ublis© 2015  The  Authors.  P
. Introduction
T helper cells play a fundamental role in the adaptive immune
esponse upon vaccination, since they are required for the induc-
ion of effector as well as memory immune responses [1–3].
haracterization of T-cell priming induced by a vaccination strategy
s critical in order to develop optimal prime-boost combinations
apable of eliciting the type of immune response required to ﬁght
 speciﬁc pathogen [4]. Magnitude, quality and localization of pri-
ary T helper (Th) cell responses are of fundamental importanceor the evaluation of novel vaccine candidates. T-cell priming can
e evaluated as a target for improving and modulating the immune
esponse during vaccination [5], and as an early predictor of vaccine
∗ Corresponding author at: Università di Siena, Dipartimento di Biotecnolo-
ie Mediche, Laboratorio di Microbiologia Molecolare e Biotecnologia (LA.M.M.B.),
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E-mail address: annalisa.ciabattini@unisi.it (A. Ciabattini).
ttp://dx.doi.org/10.1016/j.vaccine.2015.09.024
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article
.0/).hed  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
immunogenicity [6,7]. CD4+ T-cell priming has been studied to
characterize the mechanism of action of a broad range of adjuvants
such as alum [8], CpG ODN [9], lipopolysaccharide [10], cholera
toxin [11] or its B subunit (CTB) [12].
The analysis of T helper cell subsets allows the characterization
of the specialized effector cells elicited by vaccination. Upon anti-
gen encounter, clonally expanded CD4+ T cells differentiate into
various functionally deﬁned effector subpopulations, according to
the local pro-inﬂammatory environment, the dose and the route
of the vaccine used [13–15]. Besides the Th1, Th2, Th17 and T-
reg subtypes, T follicular helper (Tfh) cells have emerged in recent
years as another CD4+ T cell subtype essential for promoting the
differentiation of activated B cells into memory B cells and long
lived plasma-cells [16]. The induction of Tfh cells is therefore a
target for vaccines aimed at stimulating a protective antibody-
mediated immune response. Tfh cells express many molecules
important for their differentiation and function, such as the fol-
licle homing chemokine receptor CXCR5, the transcriptional factor
B-cell lymphoma-6 (Bcl6), the programmed cell death-1 (PD-1)
[17].
 under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
6 ine 33
d
s
u
t
b
t
a
o
M
v
i
d
b
p
u
d
A
c
N
c
b
p
r
q
c
b
d
A
s
s
2
2
R
c
n
i
d
i
2
f
C
5
D
i
i
4
l
m
[
2
s
[
R
s824 G. Prota et al. / Vacc
The ex vivo study of primed CD4+ T cells is technically limited
ue to the very low frequency of antigen-speciﬁc T cells. Antigen-
peciﬁc T cell responses have been detected by functional assays
pon in vitro antigenic restimulation. Nevertheless, since pheno-
ypic and functional properties of reactivated cells may  be altered
y this restimulation phase [18], technologies such as the adoptive
ransfer of TCR-transgenic T cells in recipient mice [9,12,19–22,22]
nd, more recently, MHC  class II tetramers [23] have been devel-
ped and employed to study T-cell priming upon vaccination [2].
HC class II-peptide complex tetramers in particular, have pro-
ided an invaluable way of monitoring ex vivo T-cell mediated
mmune responses and quantifying the development of an antigen-
ependent response in animal studies [23–26].
In the present study we have identiﬁed and characterized,
y using the tetramer technology, CD4+ T cells speciﬁc for a
eptide of the Mycobacterium tuberculosis vaccine antigen H56
pon parenteral immunization. H56 is a promising vaccine candi-
ate consisting of 6-kDa early secretory antigenic target (ESAT-6),
g85B, and the protein Rv2660, that is a component of vaccines
urrently in clinical trials (ClinicalTrials.gov Identiﬁer numbers:
CT01967134, NCT01865487) [27]. The soluble antigen was here
ombined with the adjuvant CAF01, a liposome system that has
een shown to induce combined Th1 and Th17 responses and
romote robust long-lived memory immunity [28–30]; CAF01 has
ecently been also tested in human studies [31]. The magnitude and
uality of the peptide-speciﬁc CD4+ T cell response elicited by sub-
utaneous (SC) immunization with H56 and CAF01 was  assessed
y employing MHC  class II tetramers complexed with an Ag85B-
erived peptide, in the C57BL/6 mouse model. The expansion of
g85B-tetramer binding cells, their subtype differentiation and dis-
emination towards effector sites were analysed upon priming and
ubsequent boosting.
. Materials and methods
.1. Mice
Eight-weeks old female C57BL/6 mice, purchased from Charles
iver (Lecco, Italy) were maintained under speciﬁc pathogen-free
onditions at the University of Siena, and treated according to
ational guidelines (Decreto Legislativo 26/2014). All animal stud-
es were approved by the Ethics Committee “Comitato Etico Locale
ell’Azienda Ospedaliera Universitaria Senese” and the Italian Min-
stry of Health (number 4/2011, on date 20/07/2011).
.2. Immunizations and sample collection
Mice were immunized by the SC route with the M. tuberculosis
usion protein H56 [27] (10 g/mouse) mixed with the adjuvant
AF01 [30] (250 g dimethyldioctadecylammonium (DDA) and
0 g trehalose dibehenate (TDB)/mouse; Statens Serum Institut,
enmark). SC immunization was performed at the base of the tail
n a total volume of 150 l of TRIS HCl 10 M.  Groups of mice were
mmunized at day 0 and sacriﬁced on day 7, or boosted at week
, and sacriﬁced 7 days later. Iliac (subiliac, medial and external)
ymph nodes, lungs and spleens were collected 7 days after pri-
ary or booster immunization and treated as previously described
20].
.3. Flow cytometric analysis
Cells were incubated for 30 min  at 4 ◦C in Fc-blocking
olution (complete medium plus 5 g/ml of CD16/CD32 mAb
clone 93; eBioscience, CA, USA]) and then stained for 1 h at
T with PE-conjugated I-A(b) M.  tuberculosis Ag85B precur-
or 280–294 (FQDAYNAAGGHNAVF), or PE-conjugates human (2015) 6823–6830
class II-associated invariant chain peptide (PVSKMRMARPLLMQA)
tetramers (kindly provided by NIH MHC  Tetramer Core Facility,
Emory University, Atlanta, GA) together with APC-conjugated anti-
CXCR5 (clone 2G8, BD biosciences, CA, USA). Surface staining was
performed on ice with FITC-conjugated anti-PD-1 (clone J43), PE-
CY7-conjugated anti-CXCR3 (clone CXCR3-73, both from Biolegend,
CA, USA), HV500-conjugated anti-CD4 (clone RM4-5), HV450-
conjugated anti-CD44 (clone IM7, both from BD biosciences) and
PerCp-eFl710-conjugated anti-CD127 (clone SB/199, eBioscience).
Samples were labelled with LIVE/DEAD Fixable Near IR Dead Cell
Stain Kit according to the manufacturer’s instructions (Invitro-
gen, USA). Intracellular staining for BV605-conjugated anti-T-bet
(clone 4b10, Biolegend), PECF594-conjugated anti-Bcl-6 (clone
K112-91) and PerCPCY5.5-conjugated anti-RORt (clone Q31-378,
both from BD biosciences) was performed using the Foxp3 staining
buffer set (eBioscience) according to the manufacturer instruc-
tion. Antibodies and tetramers were titrated for optimal dilution.
CD44+ tetramer+ cells were identiﬁed using a gating strategy
based on live cells, FSC × SSC lymphocyte characteristics, singlets
and CD4+ expression; gates were set according to Fluorescence
Minus One (FMO) controls. About 106 cells were stored for each
sample acquired on LSR II ﬂow cytometer (BD biosciences); data
analysis was  performed using FlowJo software (TreeStar, OR,
USA).
2.4. Cytokine assay
IFN-, IL-4, IL-10, IL-17A, IL-2 and IL-21 production was  assessed
in culture supernatants of restimulated iliac lymph nodes cells by
Bio-Plex cytokine immunoassay (Bio-Rad). Lymphocytes were cul-
tured with 5 g/ml of H56 in complete medium for 72 h at 37 ◦C in
5% CO2. IFN-, IL-4, IL-10, IL-17A, IL-2 cytokines were detected in
supernatants using the 5-plex assay system, while IL-21 was  ana-
lysed individually. Cytokine detection was performed following the
manufacturer’s protocol, and analysed by Luminex 100 (Bio-Rad).
Cytokine concentrations were calculated based on standard curve
data using Bio-Plex Manager software (version 4.0).
2.5. Statistical analysis
Two-tailed Student’s t-test was  employed to analyse statistical
differences between the frequencies of Ag85B-speciﬁc CD4+ T cells
detected in primed and boosted groups, and between the percent-
age of T-helper subsets detected in primed and boosted groups.
Statistical signiﬁcance was deﬁned as P ≤ 0.05. Graphpad 4.0 soft-
ware was used for analysis.
3. Results
3.1. Primed Ag85B-speciﬁc CD4+ T cells differentiate into multiple
Th subtypes according to their localization.
The primary antigen-speciﬁc CD4+ T-cell response was studied
after SC immunization with H56 plus CAF01 adjuvant in lymph
nodes draining the immunization site (dLN), spleen and also in
the lungs, that are an essential effector site for ﬁghting airways
pathogens. CD4+ T cells speciﬁc for the immunodominant epitope
of Ag85B, that is part of the H56 fusion protein, were identiﬁed
using Ag85B280–294-complexed MHC  class II tetramers. Staining
speciﬁcity of Ag85B280–294-complexed MHC  class II tetramers was
determined using a control tetramer complexed with an unre-
lated antigen that showed a level of staining below 0.02% (data
not shown). Tetramer-positive (Tet+) T cell subtypes were charac-
terized 7 days after priming for the expression of surface markers
and transcription factors indicative of Tfh, Th1, and Th17 sub-
type differentiation. Tfh cell phenotype was identiﬁed by assessing
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Fig. 1. Characterization of Ag85B-speciﬁc CD4+ T cell subpopulations in lymph nodes draining the immunization site. C57BL/6 mice were primed with H56 and CAF01 by the
SC  route, and sacriﬁced 7 days later. Lymphocytes from dLN were collected, stained with Ag85B280–294 MHC  class II tetramer, and analysed for the expression of surface markers
and  intracellular transcription factors for identifying different subpopulations. (A) Detection of Tet+ T cells as CD44high Tet-Ag85B+ cells gated on live CD4+ lymphocytes
(a);  percentage of Tet+ T cells respect to CD4+ T cells is reported. Gated Tet+ T cells were assessed for the expression of CXCR5 and PD-1 cells (b), and double-positive cells
(indicated as Tfh, with frequency respect to Tet+ T cells) were analysed for Bcl-6 expression (c, ﬁlled histogram; in overaly Bcl-6 expression assessed in CD4+CD44− tetramer−
cells, open histogram). Both Tfh and non-Tfh cells were assessed for the expression of CXCR3 (d and e, percentages reported are referred to Tfh and non-Tfh cells respectively),
and  non-Tfh CXCR3+ cells were analysed for the expression of T-bet (f, ﬁlled histogram, in overlay its expression assessed in CD4+CD44−tetramer− cells, open histogram).
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lot  analysis. Dot plots represent a single animal from 2 independent experiments 
he expression of PD-1 and CXCR5 together with the intracellular
xpression of Bcl-6 [33], Th1 cells were detected by the expression
f CXCR3 and T-bet [34], while Th17 by RORt [35]. Antigen-speciﬁc
D4+ T cells were not detected using MHC  class II tetramers spe-
iﬁc for the ESAT6 peptide (QQWNFAGIEAAASA, data not shown),
urther conﬁrming the immunodominance of the selected Ag85B
pitope, as shown also in previous studies [32].
.2. T helper subpopulations in dLN
In dLN Tet+ T cells expanded (0.32% of total CD4+ T cells) and
ifferentiated into several T helper cell subpopulations (Fig. 1A).
bout 20% of Tet+ T cells expressed the Tfh surface markers PD- and CXCR5 (Fig. 1A, panel b) and these gated cells expressed at
igh levels the speciﬁc Bcl-6 transcription factor (Fig. 1A, panel c).
bout 40% of gated Tfh cells expressed CXCR3, a marker preferen-
ially maintained by cells committed to the Th1 cell pathway [36]T cells), and gated positive cells were analysed for the expression of Bcl-6 versus
 (green), Bcl-6 (orange), and T-bet (blue) expression across CXCR5 versus PD-1 dot
 mice each; about 106 cells were stored for each sample.
(Fig. 1A, panel d), but they did not express the Th1 master regula-
tor factor T-bet (data not shown). It has been previously reported
that circulating CD4+CXCR5+ T cells can express CXCR3 [37], here
we show that also lymph node resident Tfh cells can express this
chemokine receptor. Among non-Tfh gated cells (Fig. 1A, panel b)
60% expressed CXCR3 (Fig. 1A, panel e), and most of them were T-
bet-positive (Fig. 1A, panel f) indicating the differentiation into Th1
cells. CXCR3+T-bet+ Th1 cells thus made up about 27% of the Tet+ T
cells.
About 40% of Tet+ T cells expressed the Th17 master regu-
lator factor RORt (Fig. 1A, panel g), and interestingly, many of
gated RORt+ cells co-expressed other master regulator factors,
such as Bcl-6 (22%) or T-bet (21%), while about 55% were pos-
itive only for RORt (Fig. 1A, panel h). This analysis shows the
presence of “transitional” phenotypes in which the co-expression
of more than one “master” transcription factor can be due to a
transient status of cells that were redirecting their phenotype and
6826 G. Prota et al. / Vaccine 33 (2015) 6823–6830
Fig. 2. Characterization of Ag85B-speciﬁc CD4+ T cell subpopulations in spleen and lungs. C57BL/6 mice were primed with H56 and CAF01 by the SC route, and sacriﬁced
7  days later. Lymphocytes from SPL (A) and lungs (B) were collected, stained with Ag85B280–294 MHC  class II tetramer, and analysed for the expression of surface markers
and  intracellular transcription factors for identifying different subpopulations. (A) Detection of Tet+ T cells as CD44high Tet-Ag85B+ cells gated on live CD4+ lymphocytes (a);
percentage of Tet+ T cells respect to CD4+ T cells is reported. Gated Tet+ T cells were assessed for the expression of CXCR5 and PD-1 (b) and double-positive cells (indicated as
Tfh,  with frequency respect to Tet+ T cells in brackets) were analysed for Bcl-6 expression (c, ﬁlled histogram; in overlay Bcl-6 expression assessed in CD4+CD44−tetramer−
cells, open histogram). Non-Tfh cells were analysed for the expression of CXCR3 (panel d, percentage reported is referred to non-Tfh cells), and gated CXCR3+ cells were
analysed for the expression of T-bet (e, ﬁlled histogram, in overlay its expression assessed in CD4+ CD44− tetramer− cells, open histogram). Tet+ T cells were tested for RORt
expression (f, percentage reported is referred to Tet+ T cells), and gated positive cells were analysed for the expression of Bcl-6 versus T-bet (g, percentages reported in each
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unction towards one speciﬁc subtype. Cells expressing RORt were
qually distributed between CXCR5 and PD-1 positive or negative
ubpopulations, while Bcl-6 and T-bet showed a clear separation
etween these two populations (Fig. 1B). The study of T helper
ubtypes performed within dLN highlights the CD4+ T cell plas-
icity, and the close relationship between different Th cell lineages
38,39].
.3. T helper subpopulations in spleen and lungs
At the same time point, the proﬁle of primed Tet+ T cells was
nalysed into spleen and lungs. The subpopulations detected in dLN
ere observed also in the spleen but with different frequencies
Fig. 2A). Tfh cells (PD-1+CXCR5+ expressing Bcl-6) were about 8%
f Tet+ T cells, while the frequency of CXCR3+ T-bet+ Th1 cells was
round 42% (Fig. 2A, panels b, d, e). About 40% expressed RORt
Fig. 2A, panel f), of these cells, 20% co-expressed T-bet, while about
8% were positive only for RORt and only 2% co-expressed RORt
nd Bcl-6 (Fig. 2A, panel g).
The analysis performed in the lungs showed the absence of both
fh (CXCR5+PD-1+) and Th1 (CXCR5−PD-1−CXCR3+) cells (Fig. 2B,
anels b and c). About 30% of Tet+ T cells expressed RORt, and
ost of them (81%) did not co-expressed other transcription factors
Fig. 2B, panels d and e). These data show a prevalence of Th1 cells
n the spleen and RORt-positive cells in lungs.e lungs. Percentages of positive cells are reported in each dot plot. Dot plots shown
ells were stored for each sample.
3.4. Effect of booster immunization on Ag85B-speciﬁc CD4+ T cells
The response of primed Ag85B-speciﬁc CD4+ T cells and the
persistence of Th subpopulations were studied upon booster immu-
nization with H56 and CAF01 in dLN, spleen and lungs 7 days
after boosting. A signiﬁcant increase in the percentage of Tet+ T
cells was  observed in all investigated organs indicative of the recall
response, and the frequencies of Tet+ T cells increased to 0.56%, 1%
and 2.3% in dLN, spleen and lungs, respectively (P < 0.001, P < 0.01
and P < 0.05 respect to primed groups; Fig. 3A). The amount of Tet+ T
cells after booster immunization was about 40,000 ± 8,000 cells in
dLN, 42,000 ± 10,000 in lungs, and 183,000 ± 54,000 in the spleens
(mean value ± SEM of 15 mice), and the fold-increase respect to the
amount generated by the primary immunization was 7.2, 4.2 and
2.6 in lungs, spleen and dLN, respectively (data not shown). CD127
expression, that is believed to be indicative of memory, was  ana-
lysed in Tet+ T-cells. After booster immunization the frequency of
Tet+ CD44hiCD127+ antigen-experienced T cells increased respect
to primed cells (Fig. 3B). The frequency, as well as the absolute
number, of PD-1+CXCR5+ Tfh cells detected upon priming, signiﬁ-
cantly decreased following booster immunization both in dLN and
spleens (Fig. 4A), while the percentage of Th1 and Th17 cells were
steadily maintained in all organs (Fig. 4A). The analysis of functional
activity of T cells collected from dLN correlated with the phenotype
observed, as shown by the production of IFN- and IL-17, while
G. Prota et al. / Vaccine 33 (2015) 6823–6830 6827
Fig. 3. Frequency of Ag85B-speciﬁc CD4+ T cells following booster immunization. C57BL/6 mice were primed with H56 and CAF01 and boosted 4 weeks later. Lymphocytes
from  dLN, SPL and lungs, collected 7 days after primary or booster immunization, were stained with Ag85B280–294 MHC  class II tetramers and surface marker antibodies.
(A)  Frequencies of Tet+ T cells respect to CD4+ cells following primary (gray) or booster immunization (black). Data are reported as the mean ± SEM of 15 mice from three
independent experiments. Two-tailed Student’s t-test was used for comparing values. *P < 0.05, **P < 0.01, and ***P < 0.001. (B) CD44 versus CD127 expression on CD4+
tetramer-Ag85B+ gated cells following primary (left) or booster (right) immunization in dLN (top panels), spleen (middle panels) and lungs (bottom panels). Percentages of
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he release of IL-2 was indicative of the proliferative response and
ctivation program of Tet+ T cells (Fig. 4B).
. Discussion
The present work explores the antigen-speciﬁc CD4+ T prolifera-
ion and differentiation into T helper suptypes following parenteral
mmunization with the vaccine formulation H56 and CAF01. Our
ata highlight that the peptide-speciﬁc population, identiﬁed by
HC  class II tetramers, produced different effector cell patterns
pon antigen encounter, and that the frequency of subpopula-
ions differed according to their localization. In particular, Tfh,
h1 and RORt+ cells were all induced into dLN together with
transitional” subtypes that co-expressed multiple helper T cell
ineage-specifying transcription factors. Tfh cells were largely har-
oured within LN draining the immunization site, while Th1 cells
ere predominant in the spleen, and RORt+ cells in the lungs.
herefore, our results show that primed T helper cells that recog-
ized the same peptide-MCH class II complex, did not differentiate
nto a single polarized phenotype but in more subtypes, that Dot plots represent a single animal from 2 independent experiments with 5 mice
showed a different fate upon reactivation. Although the cytokine
milieu it is known to play an important role in determining the
types of effector cells generated, recent evidence has demonstrated
that signals received through the TCR are also important for effector
cell differentiation [26]. The interclonal and intraclonal functional
heterogeneity of CD4+ T cells primed by pathogens or vaccines has
also been recently demonstrated by TCR deep sequencing [40], thus
supporting the one-cell multiple fates model of helper T cells dif-
ferentiation. The CD4+ T-cell response that we  have tracked using
Ag85B epitope-speciﬁc tetramers, can be considered representa-
tive of the response towards the whole vaccine, since it has been
previously shown to be an immunodominant peptide [32] and the
staining with tetramers speciﬁc for other epitopes included in H56,
did not identify any population.
Generation of Tfh cells is essential for the efﬁcacy of vaccines in
which antibody response is strongly required. Ag85B-speciﬁc Tfh
cells were detected upon priming within dLN, and with a lower
frequency in the spleen. Whether Tfh cells establish a persistent
local memory compartment is still poorly understood, as it is not
clear if Tfh are terminally differentiated cells or can give rise to
6828 G. Prota et al. / Vaccine 33 (2015) 6823–6830
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Fig. 4. Ag85B-speciﬁc CD4+ T cells upon booster immunization. Groups of C57BL/6 mice were primed with H56 and CAF01 and boosted 4 weeks later. Lymphocytes from
dLN,  SPL and lungs were collected 7 days after primary or booster immunization and stained with Ag85B280–294 MHC  class II tetramers, surface and intracellular antibodies.
A.  Frequencies of Tfh (CXCR5+PD-1+), Th1 (CXCR5−PD-1−CXCR3+), and Th17 (Bcl-6−T-bet−RORt+) cells respect to Tet+ T cells in dLN, SPL and lungs following primary
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mmunoassay in culture supernatants of lymphocytes restimulated with H56 for 72
ther helper T cell subsets once the germinal center reaction is
esolved [41]. Our data show the presence of antigen-experienced
D44highCD127+ Tet+ T cells within dLN after booster immuniza-
ion, nevertheless we observed a reduction of CXCR5 and PD-1
ouble-positive cells, while CXCR3+ Th1 cells were steadily main-
ained. Recent studies show that Tfh cells give rise to memory T
ells with unexpected plasticity that allow them to re-differentiate
lso into conventional helper T cells [41]. This supports the idea that mice from two independent experiments. Frequencies of different subpopulations
1. (B) IL-2, IFN,  IL-17, IL-4, IL-10 and IL-21 concentrations assessed by Bio-Plex
llected from dLN of naive (white), primed (dotted) or boosted (gray) mice.
Tfh cells are not terminally differentiated, and maintain a close rela-
tionship with other Th cell lineages. The developmental plasticity
model of Th differentiation is also supported by the transcription
factors analysis that we  performed among Tet+ T cells after prim-
ing. The analysis clearly showed not only the presence of “deﬁned”
Th subpopulations, such as Tfh and Th1, but also of transitional
phenotypes, in which the co-expression of more than one “master”
transcription factor was  observed. We  detected CXCR5+PD-1+ cells
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hat expressed Bcl-6 together with RORt, or CXCR5−PD-1−CXCR3+
ells positive for both RORt and T-bet. While the co-expression
f RORt and T-bet has been frequently reported [39], more stri-
ingly is the expression of RORt within CXCR5+PD-1+Bcl-6+ cells.
n general, there is a high degree of uncertainty as to whether
h17 cells represent a stable, terminally differentiated Th lineage.
ome studies have highlighted that Th17 cells can provide help
o B cells and promote GC formation including isotype switching
42], or that intestinal Th17 cells acquired a Tfh phenotype within
eyer’s patches and induced the development of IgA-producing
erminal center B cells [43]. Taken together, these data suggest that
he concomitant expression of RORt and Bcl-6 lineage-specifying
ranscription factors can be due to a transient status of cells that
ere redirecting their phenotype and function towards one speciﬁc
ubtype, in accordance with a plastic, more than deﬁned, model of
 cell differentiation [39].
Following parenteral immunization, primed and boosted
g85B-speciﬁc CD4+ T cells were detected also in the lungs. We
an speculate that most of reactivated cells exit the dLN to dissem-
nate into lungs, but also that lung tissue-resident memory cells,
enerated by primary immunization, were reactivated in situ by
ooster immunization. It has been demonstrated that it is tech-
ically complex to distinguish parenchyma-associated from lung
lood vasculature circulating cells [44]; therefore we are currently
orking for characterizing the actual localization of these cells
unpublished data). The phenotypic analysis of Tet+ T cells asso-
iated with the lungs showed characteristics different from cells
etected in the lymphoid compartments, as shown by the absence
f Tfh and Th1 cells. Since CXCR3 affects trafﬁcking of effector T
ells to the lungs upon intranasal infection [45,46], the low expres-
ion of CXCR3 on Tet+ T cells could mean that cells were already
esident in the lungs. Nevertheless, it is also possible that other
hemokines can mediate Tet+ T cells migration to the lungs, follow-
ng a parenteral immunization. Interestingly, Ag85B-speciﬁc CD4+
 cells detected in the lungs expressed prevalently RORt as single
aster transcription factor in line with pre-clinical data obtained
ith CAF01 adjuvant that observed the induction of Th17 cells [29].
h17 cells play an important role in protective immunity against
everal pathogens, and in such cases it would be highly relevant
nd beneﬁcial to induce Th17 responses.
In conclusion, our results show that T helper cells that recognize
he same peptide-MCH class II complex differentiate into more sub-
ets, with different frequencies according to their localization. Tfh
ells were elicited and harboured within LN draining the immuniza-
ion site, while Th1 were predominant in the spleen, and RORt+
ells in the lungs. T helper cells also displayed a high degree of plas-
icity, as shown by both the presence of “transitional” subtypes that
o-expressed multiple “master regulator” factors, and phenotypes
f reactivated memory cells that were partially different from those
bserved upon priming. These data provide relevant knowledge
bout CD4+ T cell responses elicited by the vaccine formulation
56 and CAF01 and on the role of the priming event in affecting
he cellular response in the context of a vaccination strategy.
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